SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Oscient Pharmaceuticals Corp. (OSCI)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Joseph wang who wrote (3)5/21/1996 10:51:00 PM
From: Tara Cobble   of 1154
 
Joseph, thanks for the information and you may also find this interesting.

I don't understand but sometimes this thread is here and other times
it is not. I have sent a question to the webmaster to get explanation.

My broker feels that GENE is trying to get another agreement signed with
a large Phar. company. This is obviously important to GENE and an important
part of the head honcho at GENE.

I am trying to get a copy of the report, it was from Oppenheimer. And they
predict it should be valued at $25 in 18 months. My understanding is that
Oppenheimer does not pass these types of recs. out lightly.

GENE is also working on a human gene program, and this should be very big news.

Mark Lambert (biggest and very successful Biotech fund investor) was very
big on GENE last year about this time. Mr. Lambert was/is very heavily
invested in GENE and had stated that it could be a $60 stock in 3 to 4 years.
That was a year ago when he said this.

Good luck and hope all this news comes true.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext